Which statement is true regarding Haloperidol?

Haloperidol is an antipsychotic medication primarily used for the treatment of psychiatric conditions such as schizophrenia and acute psychosis, as well as for severe behavioral disorders. The relevant aspect of this medication in the context of the question is its effect on seizure threshold.

Haloperidol has not been associated with a lowering of the seizure threshold; in fact, it can be utilized in some cases to manage delirium and agitation in patients who may have an increased seizure risk. By being non-contributory to a decrease in seizure threshold, it suggests that the drug can be safely used in patients where seizure activity is a concern, as opposed to other medications that might exacerbate such risks.

Therefore, stating that Haloperidol does not lower the seizure threshold correctly identifies its pharmacological properties and assures healthcare providers of its relative safety in this context when considering antipsychotic treatment for patients, particularly in palliative care settings.